Alaunos Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 21.35 K | $48.26 K | 0.00% | 0.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 19.36 K | $43.75 K | -14.20% | 0.80% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 15.50 K | $35.02 K | 0.00% | 0.64% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 14.06 K | $31.78 K | 0.00% | 0.58% |
| CITADEL ADVISORS LLC | 09/02/2026 | 11.87 K | $26.83 K | 12.84% | 0.49% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 1.73 K | $3.91 K | -2.70% | 0.07% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 1.62 K | $3.66 K | 2.40% | 0.07% |
| SRS CAPITAL ADVISORS, INC. | 08/10/2026 | 1.22 K | $2.75 K | 100.00% | 0.05% |
| UBS GROUP AG | 08/13/2026 | 992 | $2.24 K | -56.38% | 0.04% |
| MORGAN STANLEY | 08/13/2026 | 836 | $1.89 K | 28.02% | 0.03% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 501 | $1.13 K | 0.00% | 0.02% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 388 | $877 | 104.21% | 0.02% |
| ROYAL BANK OF CANADA | 08/14/2026 | 375 | $1.00 K | 102.70% | 0.02% |
| RONALD BLUE TRUST, INC. | 07/21/2026 | 135 | $305 | 0.00% | 0.01% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/13/2026 | 112 | $253 | 21.74% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2026 | 70 | $158 | 0.00% | 0.00% |
| BOKF, NA | 08/10/2026 | 66 | $149 | 100.00% | 0.00% |
| AXIOM INVESTMENT MANAGEMENT LLC | 07/31/2026 | 46 | $104 | 100.00% | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/11/2026 | 38 | $86 | 100.00% | 0.00% |
| KEY FINANCIAL INC | 07/24/2026 | 24 | $54 | 0.00% | 0.00% |
| SIGNATUREFD, LLC | 07/24/2026 | 23 | $52 | 0.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 08/14/2026 | 21 | $47 | 0.00% | 0.00% |
| NBC SECURITIES, INC. | 07/21/2026 | 20 | $45 | 0.00% | 0.00% |
| ADVISORNET FINANCIAL, INC | 07/23/2026 | 19 | $43 | 0.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 15 | $34 | 100.00% | 0.00% |
| WEST PACES ADVISORS INC. | 07/20/2026 | 10 | $23 | 100.00% | 0.00% |
| INSPIRE INVESTING, LLC | 08/12/2026 | 9 | $20 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 6 | $14 | 0.00% | 0.00% |
| IFG ADVISORY, LLC | 08/14/2026 | 6 | $14 | 100.00% | 0.00% |
| TIDEMARK, LLC | 08/10/2026 | 2 | $5 | 0.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Alaunos Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 103 institutional investors and hedge funds held shares of Alaunos Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 21,353
GEODE CAPITAL MANAGEMENT, LLC: 19,356
VANGUARD FIDUCIARY TRUST CO: 15,497
VANGUARD CAPITAL MANAGEMENT LLC: 14,063
CITADEL ADVISORS LLC: 11,870
ADVISOR GROUP HOLDINGS, INC.: 1,731
3.72% of Alaunos Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 13.81 M shares in the last 24 months. This purchase volume represents approximately $50.55 M in transactions.